PWM
Palumbo Wealth Management Portfolio holdings
AUM
$323M
1-Year Return
22.5%
This Quarter Return
+3.99%
1 Year Return
+22.5%
3 Year Return
+55.87%
5 Year Return
–
10 Year Return
–
AUM
$268M
AUM Growth
+$10.7M
(+4.1%)
Cap. Flow
+$8.98M
Cap. Flow
% of AUM
3.35%
Top 10 Holdings %
Top 10 Hldgs %
44.03%
Holding
194
New
34
Increased
97
Reduced
35
Closed
19
Top Buys
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
$20.9M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$6.65M |
| 3 |
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
|
$3.48M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
$1.36M |
| 5 |
Comcast
CMCSA
|
$1.25M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$12.7M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$8.25M |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
$5.54M |
| 4 |
iShares TIPS Bond ETF
TIP
|
$5.35M |
| 5 |
Innovator 20+ Year Treasury Bond 5 Floor ETF July
TFJL
|
$3.5M |
Sector Composition
| 1 | Technology | 15.76% |
| 2 | Financials | 7.1% |
| 3 | Consumer Discretionary | 6.87% |
| 4 | Healthcare | 6.71% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Criteo
CRTO
$1.22B
| $208K | 0.08% |
+5,264
| New | +$208K |
|
152
ProShares Ultra NASDAQ Biotechnology
BIB
$55.4M
| $203K | 0.08% |
4,000
| – | – |
|
153
Ecolab
ECL
$78B
| $201K | 0.08% |
859
+42
| +5% | +$9.84K |
|
154
Arbor Realty Trust
ABR
$2.28B
| $200K | 0.07% |
14,448
+408
| +3% | +$5.65K |
|
155
Pharvaris
PHVS
$1.41B
| $196K | 0.07% |
+10,221
| New | +$196K |
|
156
Assembly Biosciences
ASMB
$179M
| $180K | 0.07% |
+11,427
| New | +$180K |
|
157
Assertio
ASRT
$77.7M
| $179K | 0.07% |
205,598
+19,637
| +11% | +$17.1K |
|
158
Nuvation Bio
NUVB
$1.17B
| $174K | 0.06% |
65,360
+48,914
| +297% | +$130K |
|
159
MiMedx Group
MDXG
$1.05B
| $171K | 0.06% |
+17,785
| New | +$171K |
|
|
FNA
160
DELISTED
Paragon 28, Inc.
FNA
| $171K | 0.06% |
+16,553
| New | +$171K |
|
161
Treace Medical Concepts
TMCI
$453M
| $166K | 0.06% |
22,259
+9,263
| +71% | +$68.9K |
|
|
ZUO
162
DELISTED
Zuora, Inc.
ZUO
| $160K | 0.06% |
16,152
+4,616
| +40% | +$45.8K |
|
163
UiPath
PATH
$5.81B
| $144K | 0.05% |
+11,337
| New | +$144K |
|
164
Ginkgo Bioworks
DNA
$691M
| $144K | 0.05% |
+14,631
| New | +$144K |
|
165
Neuropace
NPCE
$318M
| $129K | 0.05% |
+11,517
| New | +$129K |
|
|
MTTR
166
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $124K | 0.05% |
26,073
+10,341
| +66% | +$49K |
|
167
Ocular Therapeutix
OCUL
$2.21B
| $99.9K | 0.04% |
+11,693
| New | +$99.9K |
|
168
Ardelyx
ARDX
$1.58B
| $86.4K | 0.03% |
17,041
-3,485
| -17% | -$17.7K |
|
169
OmniAb
OABI
$230M
| $75.1K | 0.03% |
21,204
-3,436
| -14% | -$12.2K |
|
170
Erasca
ERAS
$420M
| $71.8K | 0.03% |
28,600
-11,123
| -28% | -$27.9K |
|
171
Organogenesis Holdings
ORGO
$638M
| $64.6K | 0.02% |
+20,190
| New | +$64.6K |
|
|
INZY
172
DELISTED
Inozyme Pharma
INZY
| $64.5K | 0.02% |
23,281
+7,995
| +52% | +$22.1K |
|
173
Ventyx Biosciences
VTYX
$185M
| $52.4K | 0.02% |
23,932
+11,792
| +97% | +$25.8K |
|
174
Nautilus Biotechnolgy
NAUT
$82.3M
| $47.8K | 0.02% |
28,475
+8,888
| +45% | +$14.9K |
|
|
ELEV
175
DELISTED
Elevation Oncology
ELEV
| $38.9K | 0.01% |
69,105
+51,590
| +295% | +$29K |
|